Literature DB >> 11278120

Efficacy of spectinomycin against Mycoplasma bovis induced pneumonia in conventionally reared calves.

F Poumarat1, D Le Grand, S Philippe, D Calavas, F Schelcher, P Cabanié, P Tessier, H Navetat.   

Abstract

Sixteen 3-week-old calves were intratracheally inoculated with Mycoplasma bovis. Follow-up consisted of regular bronchoalveolar lavages (BALs) and clinical examinations. Animals were slaughtered from 4 to 21 days after inoculation. Counts were made of the mycoplasmas and other bacteria systematically isolated from the BAL liquids and lung lobes after slaughter. On the 6th day, spectinomycin 20mg/kg was given intramuscularly in three repeated doses at 24h intervals to six randomly chosen calves. All animals had developed a persistent M. bovis infection with a maximum BAL count on the 6th day (start of treatment). Co-occuring Pasteurella multocida infection was found in most animals with a maximum rate on the 14th day. The extent of lung surface lesions varied widely (0-64%) but was greater in the later slaughtered calves. Average counts of M. bovis and P. multocida in the BAL liquids were lower in treated calves than in untreated ones but the difference was not statistically significant. However, M. bovis and P. multocida counts in the lungs of the treated group were significantly lower than in the untreated group (p=0.003 and 0.009, respectively).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278120     DOI: 10.1016/s0378-1135(00)00379-5

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  6 in total

1.  Chronic pneumonia in calves after experimental infection with Mycoplasma bovis strain 1067: characterization of lung pathology, persistence of variable surface protein antigens and local immune response.

Authors:  Kathrin Hermeyer; Inka Buchenau; Anne Thomasmeyer; Berit Baum; Joachim Spergser; Renate Rosengarten; Marion Hewicker-Trautwein
Journal:  Acta Vet Scand       Date:  2012-02-04       Impact factor: 1.695

2.  Overall decrease in the susceptibility of Mycoplasma bovis to antimicrobials over the past 30 years in France.

Authors:  Anne V Gautier-Bouchardon; Séverine Ferré; Dominique Le Grand; Agnès Paoli; Emilie Gay; François Poumarat
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

3.  EFFICACY AND SAFETY OF BAN HUANG ORAL LIQUID FOR TREATING BOVINE RESPIRATORY DISEASES.

Authors:  Bing Li; Xu-Zheng Zhou; Jian-Rong Niu; Xiao-Juan Wei; Jian-Yong Li; Ya-Jun Yang; Xi-Wang Liu; Fu-Sheng Cheng; Ji-Yu Zhang
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-01-13

4.  Mycoplasma bovis and viral agents associated with the development of bovine respiratory disease in adult dairy cows.

Authors:  Thalita Evani Silva Oliveira; Isadora Fernanda Pelaquim; Eduardo Furtado Flores; Rodrigo Pelisson Massi; Milton James Jiménez Valdiviezo; Lucienne Garcia Pretto-Giordano; Amauri Alcindo Alfieri; João Paulo Elsen Saut; Selwyn Arlington Headley
Journal:  Transbound Emerg Dis       Date:  2019-06-24       Impact factor: 4.521

5.  Mycoplasma bovis arthritis and pneumonia in calves in Jordan: An emerging disease.

Authors:  Wael M Hananeh; Waleed M Al Momani; Mustafa M Ababneh; Sameeh M Abutarbush
Journal:  Vet World       Date:  2018-12-12

6.  Histopathological findings, phenotyping of inflammatory cells, and expression of markers of nitritative injury in joint tissue samples from calves after vaccination and intraarticular challenge with Mycoplasma bovis strain 1067.

Authors:  Vemuri Rama Devi; François Poumarat; Dominique Le Grand; Renate Rosengarten; Kathrin Hermeyer; Marion Hewicker-Trautwein
Journal:  Acta Vet Scand       Date:  2014-08-19       Impact factor: 1.695

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.